Factors Associated with Anemia among People Living with HIV/AIDS Taking ART in Ethiopia

Advances in Hematology

Volumn 2019, Issue , 2019, Pages

  Gebremedhin, Ketema Bizuwork ^a   Haye, Tadesse Bedada ^a  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; AIDS PATIENT; ANEMIA; ANTIRETROVIRAL THERAPY; ARTICLE; BODY MASS; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EXPOSURE; EDUCATIONAL STATUS; FEMALE; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAL HISTORY; NUTRITIONAL STATUS; OBESITY; OCCUPATION; PLATELET COUNT; PREVALENCE; RELIGION; TEACHING HOSPITAL; UNDERWEIGHT;

EID: 85063223779     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2019/9614205     Document Type: Article

References (39)

1. N. J. Kassebaum, T. D. Fleming, A. Flaxman et al., "The global burden of anemia," Hematology/Oncology Clinics of North America, vol. 30, no. 2, pp. 247-308, 2016.
2. WHO, "Global estimates of the prevalence of anaemia in infants and children aged 6-59months," http://www.who.int/nutrition/ publications/micronutrients/globalprevalenceanaemia, 2011.
3. "United States Department of Health and Human Service National institute of Health, National Heart, Lung and blood institute. Guide to anemia," 2011, https://www.nhlbi.nih.gov/ files/docs/public/blood/anemia-inbrief yg.pdf.
4. WHO, "Towards an integrated approach for effective anaemia control," 2004, http://www.who.int/nutrition/publications/micronutrients/ WHOandUNICEF statement anaeiaen.pdf.
5. O. Ifudu, "Maximizing response to erythropoietin in treating HIV-associated anemia," Cleveland Clinic Journal of Medicine, vol. 68, no. 7, pp. 643-648, 2001.
6. "Johns Hopkins University and Parul Christian International Nutrition, Iron Deficiency and Anemia Causes, Consequences, and Solutions," http://ocw.jhsph.edu/courses/InternationalNutrition/ PDFs/Lecture5.pdf, 2005.
7. P. A. Volberding, A. M. Levine, D. Dieterich, D. Mildvan, R. Mitsuyasu, and M. Saag, "Anemia in HIV infection: clinical impact and evidence-based management strategies," Clinical Infectious Diseases, vol. 38, no. 10, pp. 1454-1463, 2004.
8. B. Dikshit, A. Wanchu,R. K. Sachdeva,A. Sharma, and R.Das, "Profile of hematological abnormalities of Indian HIV infected individuals," BMC Blood Disorders, vol. 9, article 5, 2009.
9. A.G. Alamdo, T. Fiseha,A. Tesfay, M. K. Deber, Z. M. Tirfe, and T. Tilahun, "Anemia and its associated risk factors at the time of antiretroviral therapy initiation in public health facilities of Arba Minch Town, Southern Ethiopia," Health, vol. 07, no. 12, pp. 1657-1664, 2015.
10. S. Takuva, M. Maskew, A. T. Brennan, I. Sanne, A. P. Macphail, and M. P. Fox, "Anemia among HIV-infected patients initiating antiretroviral therapy in South Africa: improvement in hemoglobin regardless of degree of immunosuppression and the initiating art regimen," Journal of Tropical Medicine, vol. 2013, Article ID 162950, 6 pages, 2013.
11. F.Masaisa, J. B. Gahutu, J.Mukiibi, J. Delanghe, and J. Philippe, "Anemia in human immunodeficiency virus-infected and uninfected women in Rwanda," The American Journal of Tropical Medicine and Hygiene, vol. 84, no. 3, pp. 456-460, 2011.
12. R. Subbaraman, B. Devaleenal, P. Selvamuthu et al., "Factors associated with anaemia in HIV-infected individuals in southern India," International Journal of STD &AIDS, vol. 20, no. 7, pp. 489-492, 2009.
13. M. Meidani, F. M. Rezaei, R. A. Mohammad, and T. K. Majid, "Prevalence, severity, and related factors of anemia in HIV/AIDS patients," Journal of Research in Medical Sciences, vol. 17, no. 2, pp. 138-142, 2012.
14. M. Alem, T. Kena, N. Baye, R. Ahmed, and S. Tilahun, "Prevalence of anemia and associated risk factors among adult HIV patients at the anti-retroviral therapy clinic at the university of gondar hospital, Gondar, Northwest Ethiopia," Open Access Scientific Reports, vol. 2, no. 3, 2013.
15. "Government of Nepal Ministry of Health &Population National Centre for AIDS &STD Control, National Antiretroviral Therapy Guidelines," 2009, http://www.who.int/hiv/ pub/guidelines/nepal art.pdf?ua=1.
16. K. Berhane, R. Karim, M. H. Cohen et al., "Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: women's interagency HIV study," Journal of Acquired Immune Deficiency Syndromes, vol. 37, no. 2, pp. 1245-1252, 2004.
17. P. S. Belperio and D. C. Rhew, "Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature," American Journal of Medicine, vol. 116, no. 7, pp. 27-43, 2004.
18. M. Assefa, W. E. Abegaz, A. Shewamare, G. Medhin, and M. Belay, "Prevalence and correlates of anemia among HIV infected patients on highly active anti-retroviral therapy at Zewditu Memorial Hospital, Ethiopia," BMC Hematology, vol. 15, no. 1, p. 6, 2015.
19. B. Enawgaw, M. Alem, M. Melku, Z. Addis, B. Terefe, and G. Yitayew, "Prevalence and associated risk factors of anemia among HIV infected children attending Gondar university hospital, Northwest Ethiopia: a cross sectional study," BMC Hematology, vol. 15, no. 1, p. 12, 2015.
20. H. Melese,M. M.Wassie,H.Woldie, A. Tadesse, andN. Mesfin, "Anemia among adult HIV patients in Ethiopia: A hospitalbased cross-sectional study," HIV/AIDS-Research and Palliative Care, vol. 9, pp. 25-30, 2017.
21. L. Gedefaw, T. Yemane, Z. Sahlemariam, andD. Yilma, "Anemia and risk factors inHAART näive andHAART experienced HIV positive persons in South West Ethiopia: a comparative study," PLoS ONE, vol. 8, no. 8, Article ID e72202, 2013.
22. K. Tadesse, F. Haile, and N. Hiruy, "Predictors of mortality among patients enrolled on antiretroviral therapy in Aksum hospital, Northern Ethiopia: a retrospective cohort study," PLoS ONE, vol. 9, no. 1,Article ID e87392, 2014.
23. H. M.Wolde,W. T. Lerebo, K. H. Girmay, and Y. A. Melaku, "Incidence and risk factors of anemia among HIV/AIDS patients taking anti-retroviral terapy at tertiary hospitals in Addis Ababa, Ethiopia: a retrospective cohort study," Journal of HIV/AIDS &Infectious Diseases, vol. 2, no. 303, 2014.
24. WHO, "WHO Hemoglobin Cut-Offs," 2001, https://www .k4health.org/toolkits/anemia-prevention/hemoglobin-cut-offs.
25. A. J. Redig and N. Berliner, "Pathogenesis and clinical implications of HIV-related anemia. HIV in heamatology," http:// asheducationbook.hematologylibrary.org/content/2013/1/377 .full.pdf, 2013.
26. WorldHealth Organization, "LabratoryGuidelines for enumerating CD4 T Lymphoctes in the context of HIV/AIDS," 2007, http://www.who.int/hiv/amds/LaboratoryGuideEnumeratingCD4TLymphocytes. pdf.
27. J. Bacovsky, "Blood count interpretation," http://public.fnol .cz/www/3ik/data/soubory en/bacovsky blood count.pdf.
28. "Center for Disease Control and Prevention, Body Mass Index considerations for Practitioners," https://www.cdc.gov/obesity/ downloads/bmiforpactitioners.pdf.
29. G. R. Pennap and K. Abubakar, "Prevalence of anemia among human immunodeficiency virus infected patients accessing healthcare in Federal Medical Center Keffi, Nigeria," International Journal of Tropical Disease &Health, vol. 10, no. 3, pp. 1-7, 2015.
30. Y. Shen, Z. Wang, H. Lu et al., "Prevalence of anemia among adults with newly diagnosed HIV/AIDS in China," PLoS ONE, vol. 8, no. 9, p. e73807, 2013.
31. C. Martin, K. Poudel-Tandukar, and K. C. Poudel, "HIV symptom burden and anemia among HIV-positive individuals: cross-sectional results of a community-based positive living with HIV (POLH) study in Nepal," PLoS ONE, vol. 9, no. 12, Article ID e116263, 2014.
32. R. Omoregie, E. U. Omokaro, O. Palmer et al., "Prevalence of anaemia among HIV-infected patients in Benin City, Nigeria," Tanzania Journal of Health Research, vol. 11, no. 1, pp. 1-4, 2009.
33. R. E. Ahumareze, J. Rankin, A. David et al., "Prevalence of anaemia and the relationship between haemoglobin concentration and CD4 count in HIV positive children on highly active antiretroviral therapy (HAART) in Lagos, Nigeria," Current Pediatric Research, vol. 20, no. 1-2, pp. 29-36, 2016.
34. Z. Tamir, J. Alemu, and A. Tsegaye, "Anemia among HIV infected individuals taking ART with and without zidovudine at Addis Ababa, Ethiopia," Ethiopian Journal of Health Sciences, vol. 28, no. 1, pp. 73-82, 2018.
35. M. Wubetu and E. Mebratu, "Assessment of the prevalence of zidovudine induced anemia among adult HIV/AIDS patients onHAART in an ethiopian hospital," OccupationalMedicine &Health Affairs, vol. 6, no. 1, 2018.
36. H. Mihiretie, B. Taye, and A. Tsegaye, "Magnitude of anemia and associated factors among pediatric HIV/aids patients attending Zewditu memorial hospital art clinic, Addis Ababa, Ethiopia," Anemia, vol. 2015, Article ID479329, 2015.
37. T. Deressa, D. Damtie, and M. Melku, "Anemia and thrombocytopenia in the cohort of HIV-infected adults in northwest Ethiopia: a facility-based cross-sectional study," The Journal of International Federation of Clinical Chemistry and Labratory Medicine, vol. 29, no. 1, 2018.
38. P. Mijiti, Z. Yuexin, L. Min, M.Wubuli, P. Kejun, andH. Upur, "Prevalence and predictors of anaemia in patients with HIV infection at the initiation of combined antiretroviral therapy in Xinjiang, China," International Journal of STD &AIDS, vol. 26, no. 3, pp. 156-164, 2015.
39. R. Sperling, "Effect of ART drug ZDV(Zidovudine)," Infectious Diseases in Obstetrics and Gynecology, vol. 6, pp. 197-203, 1998